Who invested in Signet Therapeutics?
Signet Therapeutics's investors include Green Pine Capital, 5Y Capital, Sky9 Capital and Taihill Venture.
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2026, from 1 source
Signet Therapeutics's investors include Green Pine Capital, 5Y Capital, Sky9 Capital and Taihill Venture.
Signet Therapeutics has raised $12M across 1 round since 2026.
Signet Therapeutics's most recent round was a Series A of $12M in Jan 2026.
Its most recent round, $12M in Jan 2026, is also its largest on record.
Signet Therapeutics's first round on record, in Jan 2026, was backed by Green Pine Capital, 5Y Capital and Sky9 Capital and 1 others.
Signet Therapeutics's latest named round is a Series A, in Jan 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.